Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873504 · ClinicalTrials.gov registry record · NA
Outcome Comparisons of Vibratory Airway Clearance Devices
A NA study of Airway Clearance Impairment, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT05873504: Recruiting NA study of Airway Clearance Impairment, sponsored by Rush University Medical Center.
NCT05873504 is a NA study of Airway Clearance Impairment that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05873504, a NA study of Airway Clearance Impairment, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study aims to compare the ability of a higher oscillatory index device versus a lower oscillatory index device on airway secretion clearance and other clinically significant outcomes.
Primary Outcome
The RAAT score range from 0-50.
Conditions Studied
Interventions
- DEVICE High Oscillatory Index Device
- DEVICE Low Oscillatory Index Device
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT05873504 shows while recruiting
NCT05873504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Airway Clearance Impairment appearing as the primary indexed condition, and to 2 interventions - of which High Oscillatory Index Device is the first listed.
NCT05873504 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05873504 about?
NCT05873504 is a clinical study titled "Outcome Comparisons of Vibratory Airway Clearance Devices". This pilot study aims to compare the ability of a higher oscillatory index device versus a lower oscillatory index device on airway secretion clearance and other clinically significant outcomes.
What is the current status of trial NCT05873504?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2023-05-01. Estimated completion is 2026-12-01.
What conditions does trial NCT05873504 study?
This clinical trial studies the following conditions: Airway Clearance Impairment.
What interventions are being tested in trial NCT05873504?
The interventions under investigation include: High Oscillatory Index Device (DEVICE), Low Oscillatory Index Device (DEVICE).
Who is sponsoring clinical trial NCT05873504?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05873504 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Airway Clearance Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05873504's enrollment target sits among peer trials
64 1148th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI